These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 6676140)

  • 21. [Arterial hypertension in patients on chronic hemodialysis].
    Zogović J; Mladenović Lj
    Srp Arh Celok Lek; 1996; 124(9-10):246-50. PubMed ID: 9102857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the efficacy and pharmacokinetics of conventional propranolol and a long acting preparation of propranolol.
    Leahey WJ; Neill JD; Varma MP; Shanks RG
    Br J Clin Pharmacol; 1980 Jan; 9(1):33-40. PubMed ID: 7356891
    [No Abstract]   [Full Text] [Related]  

  • 23. Zinc and copper concentration in plasma and erythrocytes of patients with chronic renal failure.
    Paniagua-Sierra JR; Pérez-López A; Diaz-Bensussen S; Solís-Alpuche L; Saavedra-Guatemala H; Exaire-Murad JE
    Arch Invest Med (Mex); 1981; 12(1):69-82. PubMed ID: 7247613
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased plasma levels of mature form of adrenomedullin in patients with chronic renal failure.
    Ishihara T; Yokota N; Hisanaga S; Fujimoto S; Hirayama N; Kato J; Kitamura K; Eto T
    Clin Nephrol; 1999 Aug; 52(2):119-23. PubMed ID: 10480223
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum erythropoietin (ESF) titers in anemia of chronic renal failure.
    de Klerk G; Wilmink JM; Rosengarten PC; Vet RJ; Goudsmit R
    J Lab Clin Med; 1982 Nov; 100(5):720-34. PubMed ID: 7130829
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Glycosylated hemoglobin in chronic renal insufficiency].
    Grassi R; Macchia M; Dazzi F
    Minerva Med; 1981 Feb; 72(4-5):233-6. PubMed ID: 7207846
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Variable plasma propranolol levels in thyrotoxicosis.
    Rubenfeld S; Silverman VE; Welch KM; Mallette LE; Kohler PO
    N Engl J Med; 1979 Feb; 300(7):353-4. PubMed ID: 759897
    [No Abstract]   [Full Text] [Related]  

  • 28. [Antihypertensive treatment with a long-acting formulation of propranolol in the aged].
    Shimamoto Y; Shimamoto H; Nakamura H
    Nihon Ronen Igakkai Zasshi; 1988 May; 25(3):267-72. PubMed ID: 3074196
    [No Abstract]   [Full Text] [Related]  

  • 29. The disposition of propranolol. I. Elimination during oral absorption in man.
    Shand DG; Rangno RE
    Pharmacology; 1972; 7(3):159-68. PubMed ID: 5054586
    [No Abstract]   [Full Text] [Related]  

  • 30. Propranolol and spurious hyperbilirubinemia.
    Belsey R; Mueggler P; Swanson JR
    JAMA; 1984 Jan; 251(1):38. PubMed ID: 6690763
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparative pharmacokinetics of propranolol and 4-hydroxypropranolol using conventional and long-acting propranolol.
    Charles BG; Ravenscroft PJ; Renshaw PJ
    J Pharm Pharmacol; 1982 Jun; 34(6):403-4. PubMed ID: 6124628
    [No Abstract]   [Full Text] [Related]  

  • 32. Propranolol in the management of hypertension in a long-term dialysis program.
    Smith EC; Dhar SK; Freedman P
    JAMA; 1974 Sep; 229(13):1777-8. PubMed ID: 4213322
    [No Abstract]   [Full Text] [Related]  

  • 33. Pharmacokinetics of dextro-, laevo- and racemic propranolol in man.
    George CF; Fenyvesi T; Conolly ME; Dollery CT
    Eur J Clin Pharmacol; 1972 Mar; 4(2):74-6. PubMed ID: 4655684
    [No Abstract]   [Full Text] [Related]  

  • 34. Low-dose oral propranolol.
    Davies R; Pickering TG; Morganti A; Bianchetti G; Morselli PL; Romankiewicz J; Laragh JH
    Lancet; 1978 Apr; 1(8068):827-8. PubMed ID: 85849
    [No Abstract]   [Full Text] [Related]  

  • 35. Early kinetics of intravenous propranolol.
    Fagan TC; Walle T; Walle UK; Conradi EC; Harmon G; Gaffney TE
    Br J Clin Pharmacol; 1982 Apr; 13(4):571-4. PubMed ID: 7066173
    [No Abstract]   [Full Text] [Related]  

  • 36. A simple and rapid fluorometric method for the estimation of 1-(2-hydroxy-3-isopropylamino-propoxy)-naphthalene hydrochloride, propranolol, in blood.
    Ambler PK; Singh BN; Lever M
    Clin Chim Acta; 1974 Aug; 54(3):373-5. PubMed ID: 4411743
    [No Abstract]   [Full Text] [Related]  

  • 37. Intravenous propranolol in patients with inflammation.
    Waller DG; Smith CL; Renwick AG; George CF
    Br J Clin Pharmacol; 1982 Apr; 13(4):577-8. PubMed ID: 7066175
    [No Abstract]   [Full Text] [Related]  

  • 38. Extracorporeal treatment for poisoning to beta-adrenergic antagonists: systematic review and recommendations from the EXTRIP workgroup.
    Bouchard J; Shepherd G; Hoffman RS; Gosselin S; Roberts DM; Li Y; Nolin TD; Lavergne V; Ghannoum M;
    Crit Care; 2021 Jun; 25(1):201. PubMed ID: 34112223
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blood levels of long-acting propranolol in normal subjects and patients with renal failure.
    Kawasaki T; Ueno M; Uezono K; Abe I; Kawazoe N; Omae T; Nakamura S; Cooper RG; Stafford LE
    Fukuoka Igaku Zasshi; 1983 Nov; 74(11):737-43. PubMed ID: 6676140
    [No Abstract]   [Full Text] [Related]  

  • 40. [Pharmacokinetics of propranolol and clonidine in patients during chronic intermittent hemodialysis treatment].
    Seiler KU; Hunecke R; Meyer GJ
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1612-4. PubMed ID: 611890
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.